RESUMEN
BACKGROUND: Oliguria is a sign of impaired kidney function and has been shown to be an early predictor of adverse prognoses in patients with acute kidney injury. The relationship between urine output (UOP) and early lactate levels in neonates with perinatal asphyxia (PA) has not been extensively explored. This study aimed to investigate the link between oliguria during the first 24 h of life and early lactate levels in neonates with PA. METHODS: The medical records of 293 term neonates with asphyxia from 9216 hospitalized newborns were retrospectively analyzed, including 127 cases designated as the oliguria group and 166 cases as controls. Peripheral arterial blood gas after PA and UOP within 24 h after birth were analyzed. Logistic regression analyses and receiver operating characteristic curve analysis were conducted. RESULTS: Oliguria occurred in 43.34% of neonates with PA. The median UOP of the oliguria and control groups were 0.65 and 1.46 mL/kg/h, respectively. Elevated lactate levels after PA are an independent risk factor for oliguria in the following 24 h (p = 0.01; OR: 1.19; 95%CI: 1.04-1.35) and show a moderate discriminatory power for oliguria (AUC = 0.62). Using a cut off value of 8.15 mmol/L, the positive and negative predictive values and the specificity were 59.34%, 63.86%, and 78.30%, respectively. CONCLUSION: Neonates with elevated lactate levels after PA face a risk of oliguria in the following 24 h. Based on early elevated lactate levels after resuscitation, especially ≥ 8.15 mmol/L, meticulously monitoring UOP will allow this vulnerable population to receive early, tailored fluid management and medical intervention.
Asunto(s)
Asfixia Neonatal , Ácido Láctico , Oliguria , Humanos , Recién Nacido , Oliguria/etiología , Oliguria/sangre , Oliguria/diagnóstico , Oliguria/orina , Asfixia Neonatal/complicaciones , Asfixia Neonatal/orina , Asfixia Neonatal/sangre , Asfixia Neonatal/diagnóstico , Asfixia Neonatal/terapia , Masculino , Femenino , Estudios Retrospectivos , Ácido Láctico/sangre , Factores de Riesgo , Curva ROC , Lesión Renal Aguda/etiología , Lesión Renal Aguda/orina , Lesión Renal Aguda/diagnóstico , Lesión Renal Aguda/sangre , Biomarcadores/orina , Biomarcadores/sangre , Análisis de los Gases de la SangreRESUMEN
BACKGROUND: Acute kidney injury (AKI) is a syndrome of reduced glomerular filtration rate and/or reduced urine flow associated with mortality in corona virus disease 2019 (COVID-19). AKI is often associated with renal tissue damage, which may lead to chronic kidney disease. Biomarkers of tissue damage may identify patients of particular risk. METHODS: In a prospective observational study of 57 patients admitted to intensive care, AKI incidence and characteristics was evaluated according to KDIGO criteria and related to days after admission. Urinary albumin, Neutrophil Gelatinase-Associated Lipocalin (NGAL), Kidney Injury Molecule 1 (KIM-1) and Plasma Tissue Inhibitor of MetalloProteinase 2 (TIMP-2) were analysed in 52 patients at admission. The majority (n = 51, 89%) of patients developed AKI, and 27 (47%) patients had predominantly oliguric AKI where oliguria was more severe than plasma Creatinine increase. Severe oliguria within first 2 days after admission was common (n = 37, 65%), whereas stage 2 and 3 AKI due to Creatinine occurred later than day 2 in 67% (12/18) of cases. Renal replacement therapy was started in 9 (16%) patients, and 30-day mortality was 28%. Urinary biomarkers were increased in a majority of patients, but did not robustly predict KDIGO stage. Most patients had microalbuminuria, and severe albuminuria (albumin Creatinine ratio > 30 mg/mmol) was found in n = 9 (17%) patients. CONCLUSIONS: A majority of patients with COVID-19 admitted to the ICU develop AKI. The functional deficit is often low urinary volume, and initial levels of biomarkers are generally increased without clear relation to final AKI stage.
Asunto(s)
Lesión Renal Aguda/etiología , COVID-19/complicaciones , Cuidados Críticos/métodos , Oliguria/etiología , Lesión Renal Aguda/terapia , Lesión Renal Aguda/orina , Biomarcadores/orina , COVID-19/orina , Femenino , Humanos , Unidades de Cuidados Intensivos , Masculino , Persona de Mediana Edad , Oliguria/terapia , Oliguria/orina , Estudios Prospectivos , Terapia de Reemplazo Renal/métodos , SARS-CoV-2RESUMEN
BACKGROUND: This study assessed the contribution of intracorporeal (IC) and extracorporeal clearance (EC) of furosemide in patients with septic acute kidney injury (AKI), and the relationship between plasma concentrations and urine volume. METHODS: Prospective cohort observational study of 15 patients with septic AKI undergoing continuous veno-venous hemodiafiltration (CVVHDF) divided according to urine volume (< 500 ml/12 h, Oliguria group, n = 5; > 500 ml/12 h, Diuresis group, n = 10) during continuous infusion of furosemide (120 mg/12 h) at steady-state condition. Plasma and effluent furosemide concentrations were determined by high-performance liquid chromatography (HPLC)-mass spectrometry every 12 h for 48 h. RESULTS: Furosemide plasma concentrations and total body clearance (TBC) were 6.14 mg/l and 22.1 ml/min for the Oliguria group, and 2.63 mg/l and 54.4 ml/min for the Diuresis group, respectively (p < 0.05). When urine volume was < 500 ml/24 h, the furosemide plasma concentrations peaked at the potentially toxic value of 13.0 mg/l. Furosemide EC was not relevant for the Diuresis group, but it represented 18% of TBC for the Oliguria group. Furosemide plasma concentrations correlated positively with dose infusion for both groups (r = 0.728 and 0.685, p < 0.05), and negatively with urine volume only for the Diuresis (r = - 0.578, p < 0.01) but not for the Oliguria group (r = - 0.089, p = 0.715). CONCLUSIONS: For patients with urine volume > 500 ml/12 h continuous infusion of furosemide up to 480 mg/24 h leads to increasing urine volume, which can predict furosemide plasma levels within its safety range. When the urine volume is lower, the furosemide plasma levels are increased beyond any further diuretic efficacy.
Asunto(s)
Lesión Renal Aguda/terapia , Diuresis/efectos de los fármacos , Diuréticos/farmacocinética , Furosemida/farmacocinética , Hemodiafiltración , Riñón/efectos de los fármacos , Oliguria/terapia , Choque Séptico/terapia , Lesión Renal Aguda/diagnóstico , Lesión Renal Aguda/fisiopatología , Lesión Renal Aguda/orina , Adulto , Anciano , Enfermedad Crítica , Diuréticos/administración & dosificación , Diuréticos/efectos adversos , Diuréticos/sangre , Femenino , Furosemida/administración & dosificación , Furosemida/efectos adversos , Furosemida/sangre , Humanos , Infusiones Intravenosas , Riñón/fisiopatología , Masculino , Tasa de Depuración Metabólica , Persona de Mediana Edad , Oliguria/diagnóstico , Oliguria/fisiopatología , Oliguria/orina , Estudios Prospectivos , Eliminación Renal , Choque Séptico/diagnóstico , Choque Séptico/fisiopatología , Choque Séptico/orina , Urodinámica/efectos de los fármacosAsunto(s)
Lesión Renal Aguda/etiología , Deshidratación/etiología , Abuso de Marihuana/complicaciones , Oliguria/etiología , Vómitos/etiología , Lesión Renal Aguda/sangre , Lesión Renal Aguda/orina , Adulto , Creatinina/sangre , Deshidratación/sangre , Deshidratación/terapia , Deshidratación/orina , Dronabinol/orina , Fluidoterapia , Humanos , Recuento de Leucocitos , Masculino , Abuso de Marihuana/orina , Oliguria/sangre , Oliguria/terapia , Oliguria/orina , Vómitos/sangre , Vómitos/terapia , Vómitos/orina , Pérdida de PesoRESUMEN
Background: The threshold of intraoperative urine output below which the risk of acute kidney injury (AKI) increases is unclear. The aim of this retrospective cohort study was to investigate the relationship between intraoperative urine output during major abdominal surgery and the development of postoperative AKI and to identify an optimal threshold for predicting the differential risk of AKI. Methods: Perioperative data were collected retrospectively on 3560 patients undergoing major abdominal surgery (liver, colorectal, gastric, pancreatic, or oesophageal resection) at Kyoto University Hospital. We evaluated the relationship between intraoperative urine output and the development of postoperative AKI as defined by recent guidelines. Logistic regression analysis was performed to adjust for patient and operative variables, and the minimum P -value approach was used to determine the threshold of intraoperative urine output that independently altered the risk of AKI. Results: The overall incidence of AKI in the study population was 6.3%. Using the minimum P -value approach, a threshold of 0.3 ml kg -1 h -1 was identified, below which there was an increased risk of AKI (adjusted odds ratio, 2.65; 95% confidence interval, 1.77-3.97; P <0.001). The addition of oliguria <0.3 ml kg -1 h -1 to a model with conventional risk factors significantly improved risk stratification for AKI (net reclassification improvement, 0.159; 95% confidence interval, 0.049-0.270; P =0.005). Conclusions: Among patients undergoing major abdominal surgery, intraoperative oliguria <0.3 ml kg -1 h -1 was significantly associated with increased risk of postoperative AKI.
Asunto(s)
Abdomen/cirugía , Lesión Renal Aguda/diagnóstico , Complicaciones Intraoperatorias/orina , Oliguria/orina , Complicaciones Posoperatorias/diagnóstico , Lesión Renal Aguda/orina , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Femenino , Humanos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/orina , Estudios Retrospectivos , Factores de Riesgo , Adulto JovenRESUMEN
BACKGROUND: Oliguria is associated with a decreased kidney- and organ perfusion, leading to organ damage and increased mortality. While the effects of correcting oliguria on renal outcome have been investigated frequently, whether urine output is a modifiable risk factor for mortality or simply an epiphenomenon remains unclear. We investigated whether targeting urine output, defined as achieving and maintaining urine output above a predefined threshold, in hemodynamic management protocols affects 30-day mortality in perioperative and critical care. METHODS: We performed a systematic review with a random-effects meta-analyses and meta-regression based on search strategy through MEDLINE, EMBASE and references in relevant articles. We included studies comparing conventional fluid management with goal-directed therapy and reporting whether urine output was used as target or not, and reporting 30-day mortality data in perioperative and critical care. RESULTS: We found 36 studies in which goal-directed therapy reduced 30-day mortality (OR 0.825; 95% CI 0.684-0.995; P = 0.045). Targeting urine output within goal-directed therapy increased 30-day mortality (OR 2.66; 95% CI 1.06-6.67; P = 0.037), but not in conventional fluid management (OR 1.77; 95% CI 0.59-5.34; P = 0.305). After adjusting for operative setting, hemodynamic monitoring device, underlying etiology, use of vasoactive medication and year of publication, we found insufficient evidence to associate targeting urine output with a change in 30-day mortality (goal-directed therapy: OR 1.17; 95% CI 0.54-2.56; P = 0.685; conventional fluid management: OR 0.74; 95% CI 0.39-1.38; P = 0.334). CONCLUSIONS: The principal finding of this meta-analysis is that after adjusting for confounders, there is insufficient evidence to associate targeting urine output with an effect on 30-day mortality. The paucity of direct data illustrates the need for further research on whether permissive oliguria should be a key component of fluid management protocols.
Asunto(s)
Cuidados Críticos/métodos , Fluidoterapia/métodos , Oliguria/mortalidad , Oliguria/orina , Humanos , Oliguria/terapia , Análisis de RegresiónRESUMEN
BACKGROUND: In infants, oliguria is defined as a urine output of <1.5 mL/kg/h. The aim of our study was to assess the impact of oliguria on urinary neutrophil gelatinase-associated lipocalin (NGAL) and serum cystatin C (CysC) levels in very-low-birth-weight infants (VLBWIs) with a normal serum creatinine (Cr) level. METHODS: Fifty-seven VLBWIs were enrolled in the study. Urinary NGAL, serum CysC and Cr levels and urinary NGAL/Cr ratios were measured. Infants with Apgar scores of >5 at 5 min and/or a serum Cr level of >1.5 mg/dL or those treated for patent ductus arteriosus were excluded. In case of antibiotic treatment, blood and urine samples were collected at ≥48 h after discontinuation of antibiotic treatment. RESULTS: There was a significant difference in gestational age between infants with oliguric episodes during hospitalization and those without, but not in birth weight, perinatal or postnatal factors. Gestational age was negatively correlated with urinary NGAL and serum CysC levels and urinary NGAL/Cr ratio (p < 0.05), whereas postnatal age was negatively correlated with serum Cr level and urinary NGAL/Cr ratio (p < 0.05). Of the 117 urine and blood samples collected, 25 (21.4%) were obtained from neonates with oliguric episodes. After adjusting for gestational age and postnatal age, comparison of samples collected in infants with and without oliguric episodes revealed significant differences in the mean level of urinary NGAL and in the urinary NGAL/Cr ratio, but not in mean serum CysC or serum Cr levels. The urinary NGAL level [area under the curve (AUC) 0.886, 95% confidence interval (CI) 0.814-0.937] and urinary NGAL/Cr ratio (AUC 0.853, 95% CI 0.775-0.911) showed significantly greater discrimination for oliguria than serum CysC (AUC 0.610, 95% CI: 0.515-0.699) or serum Cr (AUC 0.747, 95%CI 0.659-0.823) levels. CONCLUSIONS: Urinary NGAL level and urinary NGAL/Cr ratio were more sensitive markers for the presence of oliguria in VLBWIs with normal serum Cr levels than serum CysC level.
Asunto(s)
Creatinina/sangre , Cistatina C/sangre , Recién Nacido de muy Bajo Peso/orina , Lipocalina 2/orina , Oliguria/orina , Puntaje de Apgar , Área Bajo la Curva , Biomarcadores/orina , Edad Gestacional , Hospitalización/estadística & datos numéricos , Humanos , Recién Nacido , Recién Nacido de muy Bajo Peso/sangre , Unidades de Cuidado Intensivo Neonatal/estadística & datos numéricos , Pruebas de Función Renal , Oliguria/sangre , Oliguria/diagnóstico , Proteínas Proto-Oncogénicas , Estudios RetrospectivosRESUMEN
BACKGROUND: While urine flow rate ≤0.5 ml kg-1 h-1 is believed to define oliguria during cardiopulmonary bypass (CPB), it is unclear whether this definition identifies risk for acute kidney injury (AKI) . The purpose of this retrospective study was to evaluate if urine flow rate during CPB is associated with AKI. METHODS: Urine flow rate was calculated in 503 patients during CPB. AKI in the first 48 h after surgery was defined by the Kidney Disease: Improving Global Outcomes classification. Adjusted risk factors associated with AKI and urine flow rate were assessed. RESULTS: Patients with AKI [n=149 (29.5%)] had lower urine flow rate than those without AKI (P<0.001). The relationship between urine flow and AKI risk was non-linear, with an inflection point at 1.5 ml kg-1 h-1 Among patients with urine flow <1.5 ml kg-1 h-1, every 0.5 ml kg-1 h-1 higher urine flow reduced the adjusted risk of AKI by 26% (95% CI 13-37; P<0.001). Urine flow rate during CPB was independently associated with the risk for AKI. Age up to 80 years and preoperative diuretic use were inversely associated with urine flow rate; mean arterial pressure on CPB (when <87 mmHg) and CPB flow were positively associated with urine flow rate. CONCLUSIONS: Urine flow rate during CPB <1.5 ml kg-1 h-1 identifies patients at risk for cardiac surgery-associated AKI. Careful monitoring of urine flow rate and optimizing mean arterial pressure and CPB flow might be a means to ensure renal perfusion during CPB. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov NCT00769691 and NCT00981474.
Asunto(s)
Lesión Renal Aguda/etiología , Procedimientos Quirúrgicos Cardíacos/efectos adversos , Puente Cardiopulmonar , Oliguria/diagnóstico , Oliguria/etiología , Complicaciones Posoperatorias/etiología , Lesión Renal Aguda/orina , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Oliguria/orina , Complicaciones Posoperatorias/orina , Estudios Retrospectivos , Factores de RiesgoRESUMEN
Urine output (UO) criterion may increase the sensitivity of the definition of acute kidney injury (AKI). We determined whether the empirically derived definition for oliguria(<0.5 ml/kg/h) is independently associated with adverse outcome. Data analysis included hourly recorded UO from the prospective, multicenter FINNAKI study conducted in 16 Finnish intensive care units. Confounder-adjusted association of oliguria of different severity and duration primarily with the development of AKI defined by creatinine criterion (Cr-AKI) or renal replacement therapy(RRT) was assessed. Secondarily, we determined the association of oliguria with 90-day mortality. Of the 1966 patients analyzed for the development of AKI, 454 (23.1%) reached this endpoint. Within this AKI cohort, 312 (68.7%)developed Cr-AKI, 21 (4.6%) commenced RRT without Cr-AKI, and 121 (26.7%) commenced RRT with Cr-AKI. Episodes of severe oliguria (<0.1 ml/kg/h) for more than 3 h were independently associated with the development of Cr-AKI or RRT. The shortest periods of consecutive oliguria independently associated with an increased risk for 90-day mortality were 612 h of oliguria from 0.3 to <0.5 ml/kg/h, over 6 h of oliguria from 0.1 to <0.3 ml/kg/h, and severe oliguria lasting over 3 h.Thus, our findings underlie the importance of hourly UO measurements.
Asunto(s)
Lesión Renal Aguda/diagnóstico , Lesión Renal Aguda/mortalidad , Oliguria/orina , Lesión Renal Aguda/epidemiología , Anciano , Creatinina/sangre , Enfermedad Crítica , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Terapia de Reemplazo Renal , Índice de Severidad de la Enfermedad , Factores de Tiempo , OrinaRESUMEN
BACKGROUND: Low urine output (LUO) for six hours is defined as the stage that is at risk of acute renal failure. Major surgeries with a bloodless field, such as total knee arthroplasty (TKA), may be associated with LUO; however; there has been no study addressing this point. The present study evaluated the incidence of LUO and the effect of fluid balance on LUO in TKA patients during the first 24 hours after surgery. MATERIAL AND METHOD: The authors retrospectively evaluated 257 uncomplicated patients undergoing unilateral TKA during the first 24 hours after surgery. Patients' demographic data, intra-operative intravenous (IV) fluid replacement, postoperative IV fluid replacement, oral fluid intake, total fluid intake, postoperative urine output, blood collected from the drain, and the total visible fluid output during the first 24 hours after surgery were collected and evaluated. RESULTS: The incidence of LUO was 19.1% (49/257) in the studied group. There were no significant differences in patients' demographic data between the LUO and normal urine output (NUO) groups. Comparing the LUO and NUO groups, the LUO group had a lower volume of intra-operative fluid replacement, with statistical significance. There were no differences in postoperative IV fluid replacement and postoperative oral fluid intake between groups. Although 80.5% of the studied group had LV fluid replacement at a less than ideal level, at discharge there was no patient suffering from renal complications related to LUO. DISCUSSION AND CONCLUSION: Urine output is one of the common monitoring parameters of fluid balance in the perioperative period; it should be ≥ 0.5 mL/kg/h. Prolonged low urine output for six hours and for 12 hours are categorized as causing risk and injury to the kidney, respectively. The incidence of LUO at our institution during the first 24 hours after TKA is not uncommon and is significantly related to intra-operative fluid replacement. Fortunately, all LUO patients had further fluid replacement, resulting in no renal complications at discharge. As eighty percent of patients had less than ideal fluid replacement, and patients having LUO during the first 24 hours had a significantly lower volume of intra-operative fluid replacement, the authors propose reconsidering perioperative fluid replacement in TKA patients, especially intra-operative IV fluid to avoid LUO.
Asunto(s)
Artroplastia de Reemplazo de Rodilla/efectos adversos , Oliguria/etiología , Oliguria/orina , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/orina , Estudios RetrospectivosAsunto(s)
Oliguria/sangre , Oliguria/orina , Insuficiencia Renal/sangre , Insuficiencia Renal/orina , Femenino , Humanos , MasculinoRESUMEN
PURPOSE: Oliguria is a common symptom in critically ill patients and puts patients in a high risk category for further worsening renal function (WRF). We performed this study to explore the predictive value of biomarkers to predict WRF in oliguric intensive care unit (ICU) patients. PATIENTS AND METHODS: Single-center prospective observational study. ICU patients were included when they presented a first episode of oliguria. Plasma and urine biomarkers were measured: plasma and urine neutrophil gelatinase-associated lipocalin (pNGAL and uNGAL), urine α1-microglobulin, urine γ-glutamyl transferase, urine indices of tubular function, cystatin C, C terminal fragment of pro-arginine vasopressin (CT-ProAVP), and proadrenomedullin (MR-ProADM). RESULTS: One hundred eleven patients formed the cohort, of whom 41 [corrected] had worsening renal function. Simplified Acute Physiology Score (SAPS) II was 41 (31-51). WRF was associated with increased mortality (hazard ratio 8.65 [95 % confidence interval (CI) 3.0-24.9], p = 0.0002). pNGAL, MR-ProADM, and cystatin C had the best odds ratio and area under the receiver-operating characteristic curve (AUC-ROC: 0.83 [0.75-0.9], 0.82 [0.71-0.91], and 0.83 [0.74-0.90]), but not different from serum creatinine (Screat, 0.80 [0.70-0.88]). A clinical model that included age, sepsis, SAPS II, and Screat had AUC-ROC of 0.79 [0.69-0.87]; inclusion of pNGAL increased the AUC-ROC to 0.86 (p = 0.03). The category-free net reclassification index improved with pNGAL (total net reclassification index for events to higher risk 61 % and nonevents to lower 82 %). CONCLUSIONS: All episodes of oliguria do not carry the same risk. No biomarker further improved prediction of WRF compared with Screat in this selected cohort of patients at increased risk defined by oliguria.
Asunto(s)
Oliguria/sangre , Oliguria/orina , Insuficiencia Renal/sangre , Insuficiencia Renal/orina , Proteínas de Fase Aguda/orina , Adrenomedulina/orina , Anciano , alfa-Globulinas/orina , Biomarcadores/sangre , Biomarcadores/orina , Cistatina C/orina , Progresión de la Enfermedad , Femenino , Glicopéptidos/orina , Humanos , Unidades de Cuidados Intensivos , Pruebas de Función Renal , Lipocalina 2 , Lipocalinas/sangre , Lipocalinas/orina , Masculino , Persona de Mediana Edad , Puntuaciones en la Disfunción de Órganos , Valor Predictivo de las Pruebas , Estudios Prospectivos , Precursores de Proteínas/orina , Proteínas Proto-Oncogénicas/sangre , Proteínas Proto-Oncogénicas/orina , Insuficiencia Renal/terapia , gamma-Glutamiltransferasa/sangre , gamma-Glutamiltransferasa/orinaRESUMEN
PURPOSE: To investigate the effect of no water removal (NWR) on preservation of residual renal function (RRF) in new hemodialysis (HD) patients. METHODS: Fifty-six patients with a daily urine volume ≥ 1,000 mL were included. Patients were randomized to different fluid management groups of NWR or water removal (WR) for 6 months. If predialysis BP was >150/90 mmHg, patients could take antihypertensive drugs. The primary endpoints included death, cardio-cerebral vascular disease, refractory hypertension, and edema or an auxiliary examination indicating obvious fluid retention. The secondary endpoint was oliguria. A daily urine volume, 24-h urine creatinine clearance, the defined daily dose (DDD) index of antihypertensive drugs, erythropoietin resistance index, cardiothoracic ratio, and left ventricular mass index (LVMI) were recorded. RESULTS: Eight patients in the NWR group reached the primary endpoints. Nine patients in the WR group reached the secondary endpoint. At the end of the study, patients in the NWR group had more increased systemic blood pressure (9.0 ± 8.3 vs. -2.4 ± 2.0 mmHg, p < 0.001), DDD index (1.2 ± 1.02 vs. -0.9 ± 0.51, p < 0.001), daily urine volume (164 ± 351 vs. -726 ± 342 mL, p < 0.001), cardiothoracic ratio (0.02 ± 0.04 vs. -0.03 ± 0.03, p < 0.001), LVMI (9.6 ± 17.0 vs. -12.0 ± 21.4 g/m(2), p < 0.001), and less decreased urine creatinine clearance (-1.0 ± 0.4 vs. -2.0 ± 1.0, p < 0.001), compared with those patients in the WR group. CONCLUSIONS: Preservation of RRF by NWR is warranted in new HD patients, but is not appropriate for all patients.
Asunto(s)
Hipertensión/etiología , Fallo Renal Crónico/fisiopatología , Fallo Renal Crónico/terapia , Riñón/fisiopatología , Diálisis Renal/métodos , Agua/metabolismo , Adulto , Presión Sanguínea , Creatinina/sangre , Creatinina/orina , Edema/etiología , Femenino , Insuficiencia Cardíaca/etiología , Humanos , Hipertensión/tratamiento farmacológico , Fallo Renal Crónico/orina , Masculino , Persona de Mediana Edad , Oliguria/etiología , Oliguria/orina , Selección de Paciente , Diálisis Renal/efectos adversos , Remodelación VentricularRESUMEN
Hypertension is commonly encountered in pregnancy and has both maternal and fetal effects. Acute hypertensive crisis most commonly occurs in severe preeclampsia and is associated with maternal stroke, cardiopulmonary decompensation, fetal decompensation due to decreased uterine perfusion, abruption, and stillbirth. Immediate stabilization of the mother including the use of intervenous antihypertensives is required and often delivery is indicated. With appropriate management, maternal and fetal outcomes can be excellent.
Asunto(s)
Antihipertensivos/uso terapéutico , Hidralazina/uso terapéutico , Preeclampsia/diagnóstico , Complicaciones Cardiovasculares del Embarazo/diagnóstico , Bloqueadores de los Canales de Calcio/uso terapéutico , Creatina/orina , Diuréticos/uso terapéutico , Medicina de Emergencia , Femenino , Monitoreo Fetal/métodos , Humanos , Infusiones Intravenosas , Labetalol/uso terapéutico , Metildopa/uso terapéutico , Nifedipino/uso terapéutico , Nitroprusiato/uso terapéutico , América del Norte/epidemiología , Oliguria/orina , Preeclampsia/tratamiento farmacológico , Preeclampsia/mortalidad , Preeclampsia/orina , Embarazo , Complicaciones Cardiovasculares del Embarazo/tratamiento farmacológico , Complicaciones Cardiovasculares del Embarazo/mortalidad , Complicaciones Cardiovasculares del Embarazo/orina , Proteinuria/orinaRESUMEN
Decreased urine output and acute kidney injury (also known as acute renal failure) are among the most important complications that may develop in the postanesthetic period. In this article, the authors present definitions of decreased urine output, oliguria, and acute kidney injury. They review the epidemiology, pathophysiology, and prevention of postoperative acute kidney injury. Finally, the article offers approaches to diagnosis and management of the postsurgical patient with decreased urine output or acute kidney injury.
Asunto(s)
Lesión Renal Aguda/orina , Anestesia , Cuidados Posoperatorios/métodos , Complicaciones Posoperatorias/orina , Micción/fisiología , Orina/fisiología , Lesión Renal Aguda/epidemiología , Lesión Renal Aguda/prevención & control , Lesión Renal Aguda/terapia , Periodo de Recuperación de la Anestesia , Unidades Hospitalarias , Humanos , Oliguria/etiología , Oliguria/orina , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/prevención & control , Complicaciones Posoperatorias/terapia , Factores de RiesgoRESUMEN
The aim of the study was to find out if there is an optimal mean arterial blood pressure (MABP) during cardiopulmonary bypass (CPB) for renal function in elderly patients during the early postoperative period. We analysed the data of 122 patients >70 years of age with normal preoperative renal function who had been subjected to coronary artery bypass grafting (CABG) procedures on CPB. Patients were divided into 3 groups, according to MABP during CPB: group MP (n=50) included patients whose MABP was maintained between 60-70 mmHg; group LP (n=36), the MABP was <60 mmHg; and group HP (n=36) where the MABP was >70 mmHg. The patients' clinical data were evaluated during the first three postoperative days. The rate of renal impairment (urine output <50ml/h) in the early postoperative period after cardiac surgery did not differ among the groups. Oliguria developed in 3 patients (6%) of the MP group, in 2 patients (5.6%) in the LP group and in 6 patients (16.7%) in the HP group (χ(2)=3.6, df=2, p=0.161). Evaluation of MABP on renal excretion showed that there was no difference in urine output among the groups. Serum creatinine levels at the end of the first postoperative day in groups MP, LP and HP were 102.7±20.1, 116.4±58.6 and 113.2±39.8 µmol/L, respectively (F=0.5, df=2, p=0.640). There were no significant differences among the groups at the end of the second and the third day either. Volume balance at the end of surgery and during the early postoperative period was similar in all groups. The need for diuretics did not differ among the groups. The length of postoperative hospital stay was not significantly different among the groups. Our study did not reveal any relationship between a MABP of 48-80 and postoperative renal dysfunction in elderly patients after CABG surgery.
Asunto(s)
Presión Sanguínea , Puente Cardiopulmonar , Puente de Arteria Coronaria , Enfermedades Renales/fisiopatología , Riñón/fisiopatología , Oliguria/fisiopatología , Anciano , Creatinina/sangre , Femenino , Humanos , Enfermedades Renales/sangre , Enfermedades Renales/etiología , Enfermedades Renales/orina , Pruebas de Función Renal/métodos , Tiempo de Internación , Masculino , Oliguria/sangre , Oliguria/etiología , Oliguria/orina , Periodo Posoperatorio , Urea/orinaRESUMEN
INTRODUCTION: Acute kidney injury (AKI) morbidity and mortality rates remain high. Variable AKI outcomes have been reported in association with aminophylline treatment. This study evaluated AKI outcome in a group of Nigerian children treated with aminophylline. METHODS: This is a retrospective study of AKI in children treated with (N=9) and without (N=8) aminophylline. Studied outcome indices comprised urine flow rate (UFR), duration of oliguria/anuria, progression through AKI stages, number of patients requiring dialysis and mortality. RESULTS: Mean ages for the control and aminophylline arms were 4.6±2.7 and 4.9±2.1 years (P=0.7), respectively. All patients progressed to stage-3 AKI. Baseline median UFRs in the aminophylline and control arms were similar (0.13 Vs 0.04 ml/kg/hour respectively, P=0.5). The median UFR was significantly higher on day-5 (0.8 Vs 0.1; P=0.03), day-6 (1.0 Vs 0.2; P=0.02), and day-7 (1.2 Vs 0.2; P=0.03) in the aminophylline than the control arm, respectively. Short duration of oliguria/anuria (≤ 6 days) was more frequently observed in aminophylline- treated patients compared to controls (77.8% Vs 25.0%; odds ratio 0.09; 95% CI: 0.01-0.89; P=0.04). Only the aminophylline group maintained steady serum creatinine levels. Four out of five patients in the control group were dialyzed compared to only one out of eight patients in the aminophylline group (odds ratio 0.16; 95% CI: 0.04-0.71; P=0.03). Mortality rates were similar in aminophylline- treated and control patients (33% Vs 25%; hazard ratio 0.8; 95% CI: 0.1-5.5; P=0.8). CONCLUSION: Aminophylline therapy was beneficial for patients with AKI in terms of improved UFR and reduced need for dialysis, but failed to impact positively on survival.
Asunto(s)
Lesión Renal Aguda/tratamiento farmacológico , Lesión Renal Aguda/mortalidad , Aminofilina/uso terapéutico , Diuréticos/uso terapéutico , Lesión Renal Aguda/orina , Anuria/tratamiento farmacológico , Anuria/mortalidad , Anuria/orina , Cardiotónicos/uso terapéutico , Niño , Preescolar , Progresión de la Enfermedad , Femenino , Humanos , Masculino , Oliguria/tratamiento farmacológico , Oliguria/mortalidad , Oliguria/orina , Diálisis Renal/mortalidad , Estudios Retrospectivos , OrinaRESUMEN
Oliguria is a valuable marker of kidney function and a criterion for diagnosing and staging acute kidney injury (AKI). However, the utility of urine output as a specific metric for renal dysfunction is somewhat controversial. To study this issue further we tested whether urine output is a sensitive, specific, and early measure for diagnosing and staging AKI in 317 critically ill patients in a prospective observational study. Urine output was assessed every hour and serum creatinine every 12 to 24 h. The sensitivity and specificity of different definitions of oliguria for the diagnosis of AKI were compared with the Acute Kidney Injury Network serum creatinine criterion. The incidence of AKI increased from 24%, based solely on serum creatinine, to 52% by adding the urine output as a diagnostic criterion. Oliguric patients without a change in serum creatinine had an intensive care unit mortality rate (8.8%) significantly higher than patients without AKI (1.3%), and similar to oliguric patients with an increase in serum creatinine (10.4%). The diagnosis of AKI occurred earlier in oliguric than in non-oliguric patients. Oliguria of more than 12 h and oliguria of 3 or more episodes were associated with an increased mortality rate. Thus, urine output is a sensitive and early marker for AKI and is associated with adverse outcomes in intensive care unit patients.
Asunto(s)
Oliguria/mortalidad , Lesión Renal Aguda/sangre , Lesión Renal Aguda/diagnóstico , Lesión Renal Aguda/mortalidad , Lesión Renal Aguda/orina , Adulto , Anciano , Estudios de Cohortes , Creatinina/sangre , Enfermedad Crítica , Femenino , Humanos , Unidades de Cuidados Intensivos , Masculino , Persona de Mediana Edad , Oliguria/sangre , Oliguria/orina , Pronóstico , Estudios Prospectivos , Factores de RiesgoRESUMEN
While the fractional excretion of solutes have long been considered excellent research tools to investigate tubular physiology, their clinical use has become common over the last 40 years in the diagnoses of many disorders; however, none have reached the clinical utility of the fractional excretion of sodium in the ability to distinguish pre-renal azotemia from acute tubular necrosis. Nevertheless, there are many drugs and medical conditions that interfere with that utility and recently other solutes, including urea, uric acid and lithium, have been recently investigated to improve the diagnostic ability in clinical situations where the fractional excretion of sodium is known to be unreliable. We review the tubular physiology of these solutes and show how the differences in tubular physiology might be exploited to develop a strategy for their optimal clinical use.
Asunto(s)
Lesión Renal Aguda/diagnóstico , Azotemia/diagnóstico , Riñón/fisiopatología , Oliguria/diagnóstico , Privación de Agua/fisiología , Absorción , Azotemia/fisiopatología , Azotemia/orina , Transporte Biológico Activo/fisiología , Diagnóstico Diferencial , Humanos , Médula Renal/fisiopatología , Túbulos Renales/metabolismo , Túbulos Renales/fisiopatología , Litio/metabolismo , Nefronas/metabolismo , Oliguria/fisiopatología , Oliguria/orina , Cloruro de Sodio/metabolismo , Urea/orina , Ácido Úrico/metabolismoRESUMEN
Critical care units are equipped with commercial monitoring devices capable of sensing patients' physiological parameters and supervising the achievement of the established therapeutic goals. This avoids human errors in this task and considerably decreases the workload of the healthcare staff. However, at present there still is a very relevant physiological parameter that is measured and supervised manually by the critical care units' healthcare staff: urine output. This paper presents a patent-pending device capable of automatically recording and supervising the urine output of a critical care patient. A high precision scale is used to measure the weight of a commercial urine meter. On the scale's pan there is a support frame made up of Bosch profiles that isolates the scale from force transmission from the patient's bed, and guarantees that the urine flows properly through the urine meter input tube. The scale's readings are sent to a PC via Bluetooth where an application supervises the achievement of the therapeutic goals. The device is currently undergoing tests at a research unit associated with the University Hospital of Getafe in Spain.